• Scancell, CR UK publish joint vaccine update pharmatimes
    May 28, 2019
    Scancell Holdings has announced that its ImmunoBody vaccine, SCIB2, is to be administered using a new nanoparticle formulation in a planned Phase I/II clinical trial.
PharmaSources Customer Service